According to a recent LinkedIn post from Cedar Gate Technologies, the company is closely tracking the Centers for Medicare & Medicaid Services’ new voluntary ACCESS model for chronic disease care. The post describes ACCESS as a 10‑year initiative launching July 5 that seeks to reduce costs and improve management of chronic conditions among Medicare beneficiaries through outcome‑aligned payments.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights that ACCESS is intended to expand technology‑supported care options, simplify payments for clinicians, and promote coordinated, accountable care. It also notes an emphasis on transparency to help patients and providers make more informed decisions in chronic disease management.
The post suggests that Cedar Gate’s experts attended CMS’s kickoff call to better understand how the firm’s technology could support potential ACCESS participants. As presented, this could position Cedar Gate to capture demand from providers and payers adapting to the model, potentially increasing software adoption in value‑based care arrangements.
For investors, the focus on a decade‑long CMS program may indicate a long runway of regulatory‑driven demand for chronic care and alternative payment solutions. If Cedar Gate’s platforms prove well aligned with ACCESS requirements, the initiative could enhance the company’s competitive standing within healthcare IT and value‑based care technology markets.

